Unknown

Dataset Information

0

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer.


ABSTRACT: Breast cancer bone metastasis is currently incurable, ~75% of patients with late-stage breast cancer develop disease recurrence in bone and available treatments are only palliative. We have previously shown that production of the pro-inflammatory cytokine interleukin-1B (IL-1B) by breast cancer cells drives bone metastasis in patients and in preclinical in vivo models. In the current study, we have investigated how IL-1B from tumour cells and the microenvironment interact to affect primary tumour growth and bone metastasis through regulation of the immune system, and whether targeting IL-1 driven changes to the immune response improves standard of care therapy for breast cancer bone metastasis. Using syngeneic IL-1B/IL1R1 knock out mouse models in combination with genetic manipulation of tumour cells to overexpress IL-1B/IL1R1, we found that IL-1B signalling elicited an opposite response in primary tumours compared with bone metastases. In primary tumours, IL-1B inhibited growth, by impairing the infiltration of innate immune cell subsets with potential anti-cancer functions but promoted enhanced tumour cell migration. In bone, IL-1B stimulated the development of osteolytic metastases. In syngeneic models of breast cancer, combining standard of care treatments (Doxorubicin and Zoledronic acid) with the IL-1 receptor antagonist Anakinra inhibited both primary tumour growth and metastasis. Anakinra had opposite effects on the immune response compared to standard of care treatment, and its anti-inflammatory signature was maintained in the combination therapy. These data suggest that targeting IL-1B signalling may provide a useful therapeutic approach to inhibit bone metastasis and improve efficacy of current treatments for breast cancer patients.

SUBMITTER: Tulotta C 

PROVIDER: S-EPMC8295314 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2023-08-15 | GSE229428 | GEO
2023-08-15 | GSE229426 | GEO
2023-08-15 | GSE229422 | GEO
| S-EPMC5762736 | biostudies-other
| S-EPMC6755966 | biostudies-literature
| S-EPMC8570367 | biostudies-literature
| S-EPMC6461960 | biostudies-literature
| S-EPMC8788950 | biostudies-literature
| S-EPMC8348084 | biostudies-literature
| S-EPMC3895218 | biostudies-literature